R&D News | pharmaphorum

News

AstraZeneca partners Capitainer on biomarker project

Swedish medtech start-up Capitainer has started working with AstraZeneca on a project to use a device for sampling cell-free blood in clinical trial programmes.

News

Trial sets up earlier use of J&J's Carvykti in myeloma

One of Johnson & Johnson's top clinical trial readouts for 2023 just generated results, which bode very well for the future prospects of multiple myeloma CAR-T Carvykti.

News

UK biotech sees worst funding downturn since 2012

The UK BioIndustry Association (BIA) and data and insights company Clarivate have released their annual UK Biotech Financing report

News

How effective data management can support NHS Trusts to hit their targets

Roche, Boehringer tap biosensor firms for patient studies

Roche and Boehringer Ingelheim have both formed partnerships with tech companies this week to develop and deploy wearable biosensor te

News

Merck's Keytruda flunks another prostate cancer test

Prostate cancer has proved an elusive target for cancer immunotherapies, and Merck & Co's checkpoint inhibitor Keytruda is the latest to fall short in the disease in a phase 3 trial.

News

Pliant seeks $250m offering on lung fibrosis data

Buoyed by encouraging mid-stage clinical results for its idiopathic pulmonary fibrosis therapy bexotegrast, Pliant Therapeutics filed a $175million public offering, and then swiftly raised

AstraZeneca partners Capitainer on biomarker project

Trial sets up earlier use of J&J's Carvykti in myeloma

UK biotech sees worst funding downturn since 2012

Roche, Boehringer tap biosensor firms for patient studies

Merck's Keytruda flunks another prostate cancer test

Pliant seeks $250m offering on lung fibrosis data

Lilly partners with Hims & Hers on obesity drug sales

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks